Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed 2
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Mar 2008 2009 2010 2011 2012 2013 TTM 2014E 2015E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 24th Jul, paid: 23rd Aug more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +12.8%

FINANCIAL BRIEF: For the six months ended 30 September 2013, Immunodiagnostic Systems Hldgs PLC revenues increased 13% to L26.9M. Net income decreased 23% to L3.6M. Revenues reflect Europe Direct segment increase of 38% to L11.8M, ROW Distribution segment increase of 18% to L6.3M. Net income was offset by UnAllocated segment loss increase of 37% to L8.4M, USA Direct segment income decrease of 58% to L692K. more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score
B+
B+

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Sep '13) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Mar 2014
31st Mar 2015

Price Target: 502.3 (-0.91% below Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
5 brokers Broker Consensus Trend
Broker Recommendations for Immunodiagnostic Systems Holdings
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 4 0 1

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity Julie Simmonds , Panmure Gordon Savvas Neophytou , N+1 Brewin , Peel Hunt Paul Cuddon , Collins Stewart & Co , Edison Investment Research , Daniel Stewart , N+1 Singer Elizabeth Klein Chris Glasper , FinnCap Keith Redpath ,

Immunodiagnostic Systems Holdings plc (IDS) is engaged in manufacturing and distributing medical diagnostic products. The Company is also involved in research and development projects. The Company’s main operation is within the in vitro diagnostic (IVD) testing industry, supplying test kits to hospital and research laboratories. The Company is also engaged in the provision of immunoassay tests for the determination of vitamin D (both 25-Hydroxy and 1,25-Dihydroxy). The Company’s product include 1,25-Dihydroxy Vitamin D EIA, 1,25-Dihydroxy Vitamin D RIA, 25-Hydroxy Vitamin D EIA, 25-Hydroxy Vitamin D RIA ,Alpha CrossLaps (CTX-I) EIA, Automated IDS-iSYS System, BoneTRAP (TRAcP 5b) ELISA, Corticosterone EIA, Corticosterone HS EIA and CrossLaps for Culture (CTX-I) ELISA.

Directors: Patrik Dahlen (CEO) 51, Christopher Yates (Fin. Dir.) 39, Martha Garrity (Exec. Dir.) 52, Alain Rousseau (Exec. Dir.) 62, Barry Hextall (Other) ,

No. of Employees: 307 No. of Shareholders: n/a


Last Annual March 31st, 2013
Last Interim September 30th, 2013
Shares in Issue 29,161,915
Free Float 21.2m (72.8%)
ISIN GB00B01YZ052
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share, FTSE Aim 100,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

IDH Share Price Performance IDH Quote
506.5p
0.0  0.0%
Traded 5:15pm · Minimum 15 min delayed · NMS: 0.500k

Latest IDH News Announcements (delayed)

Upcoming IDH Events
Tuesday 24th June, 2014
Preliminary 2013 Immunodiagnostic Systems Holdings PLC Earnings Release
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Annual General Meeting
Tuesday 14th October, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement H1 FY13-14
Tuesday 25th November, 2014
Interim 2014 Immunodiagnostic Systems Holdings PLC Earnings Release

Recent ↓
Tuesday 15th April, 2014
Immunodiagnostic Systems Holdings PLC Trading Update for the year ended 31 March 2014
Wednesday 27th November, 2013
Interim 2013 Immunodiagnostic Systems Holdings PLC Earnings Release
Thursday 10th October, 2013
Immunodiagnostic Systems Holdings PLC Trading Update for the six months ended 30 September 2013
Friday 26th July, 2013
Immunodiagnostic Systems Holdings PLC Annual General Meeting
Wednesday 24th July, 2013
Dividend For IDH.L
Monday 17th June, 2013
Preliminary 2012 Immunodiagnostic Systems Holdings PLC Earnings Release
Wednesday 10th April, 2013
Immunodiagnostic Systems Holdings PLC Trading Update for the year ended 31 March 2013
Monday 26th November, 2012
Interim 2012 Immunodiagnostic Systems Holdings PLC Earnings Release
Friday 14th September, 2012
Immunodiagnostic Systems Holdings PLC Annual General Meeting
Wednesday 5th September, 2012
Dividend For IDH.L


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2014.


Should you buy IDH

Access IDH Analytics Now!

FREE TRIAL or TAKE THE TOUR